COPD-Kranke haben unter Fluticason/Vilanterol weniger mittelschwere oder schwere Exazerbationen als unter ihrer üblichen Therapie, ohne dass das Nebenwirkungsrisiko steigt. Das hat eine randomisierte Studie unter Alltagsbedingungen ergeben. … lesen Sie weiter! Quelle: : http://www.aerztezeitung.de/medizin/krankheiten/asthma/article/920306/copd-icslaba-punktet-praxisstudie.html
Related Posts
How to recover from a night shift
Sleep deprivation is one of the main sources of errors. But many times after a night shift, you’ll have to show up the same day in the hospital for another night shift. That is why after a night shift we should start replenishing our energy levels right away. Ultimately there is only one way to recover […]
Advocacy in action: National Food Allergy Action Plan
Today we, along with the Canadian Society of Allergy and Clinical. Immunology (CSACI), are on Parliament Hill meeting with Members of Parliament and Senators to launch our National Food Allergy Action Plan. The goal of our action plan is to set the fra…
What to know about brittle asthma
Brittle asthma is a rare form of severe asthma that affects around 0.05% of people with asthma. This article looks at the causes, symptoms, and treatments of brittle asthma. Lesen Sie weiter auf: What to know about brittle asthma Quelle: Medical News Today | Asthma Titelbild/Grafik by Medical News Today | Healthline Media UK Ltd.